CRYOPORT, INC. Operating Lease, Payments
CRYOPORT, INC. (CYRX) reported Operating Lease, Payments of $3.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-06
- CRYOPORT, INC. operating lease, payments for the quarter ending 2026-06-30 was $1.83M, a 11.78% increase year-over-year.
- CRYOPORT, INC. operating lease, payments for the quarter ending 2026-03-31 was $1.97M, a 41.20% increase year-over-year.
- CRYOPORT, INC. operating lease, payments for the quarter ending 2025-12-31 was $1.78M, a 37.97% increase year-over-year.
- CRYOPORT, INC. operating lease, payments for the quarter ending 2025-09-30 was $1.98M, a 40.98% increase year-over-year.
- CRYOPORT, INC. operating lease, payments for fiscal 2025 was $6.79M, a 27.86% increase from fiscal 2024.
- CRYOPORT, INC. operating lease, payments for fiscal 2024 was $5.31M, a 14.14% increase from fiscal 2023.
- CRYOPORT, INC. operating lease, payments for fiscal 2023 was $4.65M, a 1.67% decline from fiscal 2022.
- CRYOPORT, INC. operating lease, payments for fiscal 2022 was $4.73M, a 18.53% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 9 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.81M 10-Q · filed 2026-08-06 | $5.58M derived: sum of 3 quarters · filed 2026-08-06 | $7.56M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.97M 10-Q · filed 2026-05-05 | $3.75M derived: sum of 2 quarters · filed 2026-05-05 | $5.73M derived: sum of 3 quarters · filed 2026-05-05 | $7.37M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.75M derived: sum of 2 quarters · filed 2026-03-05 | $5.39M derived: sum of 3 quarters · filed 2026-08-06 | $6.79M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $3.62M derived: sum of 2 quarters · filed 2026-08-06 | $5.01M 10-Q · filed 2025-11-06 | $6.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.04M 10-Q · filed 2026-08-06 | $4.33M derived: sum of 3 quarters · filed 2026-08-06 | $5.73M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $1.40M 10-Q · filed 2026-05-05 | $2.69M derived: sum of 2 quarters · filed 2026-05-05 | $4.09M derived: sum of 3 quarters · filed 2026-05-05 | $5.38M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.69M derived: sum of 2 quarters · filed 2026-03-05 | $3.99M derived: sum of 3 quarters · filed 2026-03-05 | $5.31M 10-K · filed 2026-03-05 | $7.86M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.70M derived: sum of 2 quarters · filed 2025-11-06 | $4.02M 10-Q · filed 2025-11-06 | $6.04M 10-Q · filed 2024-11-07 | $3.79M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $2.62M 10-Q · filed 2025-08-12 | $3.91M 10-Q · filed 2024-08-08 | $2.38M derived: sum of 3 quarters · filed 2026-03-05 | $3.95M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-03-31 | $1.32M 10-Q · filed 2025-05-08 | $1.99M 10-Q · filed 2024-05-08 | $1.09M derived: sum of 2 quarters · filed 2026-03-05 | $2.66M derived: sum of 3 quarters · filed 2026-03-05 | $4.34M derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.33M derived: sum of 2 quarters · filed 2026-03-05 | $3.02M derived: sum of 3 quarters · filed 2026-03-05 | $4.65M 10-K · filed 2026-03-05 | $6.72M 10-K · filed 2024-03-13 | |||
| 2023-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.25M derived: sum of 2 quarters · filed 2024-11-07 | $4.89M 10-Q · filed 2024-11-07 | $5.86M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.32M 10-Q · filed 2024-08-08 | $4.29M derived: sum of 3 quarters · filed 2025-03-07 | $5.61M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.64M 10-Q · filed 2024-05-08 | $2.61M derived: sum of 2 quarters · filed 2025-03-07 | $3.93M derived: sum of 3 quarters · filed 2025-03-07 | $5.16M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $969.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.29M derived: sum of 2 quarters · filed 2025-03-07 | $3.52M derived: sum of 3 quarters · filed 2025-03-07 | $4.73M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.55M derived: sum of 2 quarters · filed 2023-11-09 | $3.76M 10-Q · filed 2023-11-09 | $4.89M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.44M 10-Q · filed 2023-08-09 | $3.58M derived: sum of 3 quarters · filed 2024-03-13 | $4.67M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | $1.21M 10-Q · filed 2023-05-04 | $2.34M derived: sum of 2 quarters · filed 2024-03-13 | $3.43M derived: sum of 3 quarters · filed 2024-03-13 | $4.35M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $2.22M derived: sum of 2 quarters · filed 2024-03-13 | $3.14M derived: sum of 3 quarters · filed 2024-03-13 | $3.99M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $2.01M derived: sum of 2 quarters · filed 2022-11-04 | $2.86M 10-Q · filed 2022-11-04 | $2.86K 10-Q · filed 2021-11-04 | $3.63M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $920.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.77M 10-Q · filed 2022-08-04 | $1.77K 10-Q · filed 2021-08-06 | $2.54M derived: sum of 3 quarters · filed 2023-02-28 | $2.86M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $851.00K 10-Q · filed 2022-05-05 | $851.00 10-Q · filed 2021-05-06 | $1.62M derived: sum of 2 quarters · filed 2023-02-28 | $1.94M derived: sum of 3 quarters · filed 2023-02-28 | $2.25M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | $767.99K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.09M derived: sum of 2 quarters · filed 2023-02-28 | $1.40M derived: sum of 3 quarters · filed 2023-02-28 | $1.68M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $324.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $628.88K derived: sum of 2 quarters · filed 2020-11-06 | $912.01K 10-Q · filed 2020-11-06 | $1.07M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $304.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $587.53K 10-Q · filed 2020-08-10 | $748.74K derived: sum of 3 quarters · filed 2022-02-28 | $1.08M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $283.13K 10-Q · filed 2020-05-08 | $444.33K derived: sum of 2 quarters · filed 2022-02-28 | $774.02K derived: sum of 3 quarters · filed 2022-02-28 | $910.13K derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $161.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $490.89K derived: sum of 2 quarters · filed 2022-02-28 | $627.00K derived: sum of 3 quarters · filed 2022-02-28 | $760.00K 10-K · filed 2022-02-28 | $759.87K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $329.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $465.80K derived: sum of 2 quarters · filed 2019-11-12 | $598.80K 10-Q · filed 2019-11-12 | |||||
| 2019-06-30 | $136.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $269.11K 10-Q · filed 2019-08-09 | ||||||
| 2019-03-31 | $133.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |